Fischer Seth H. Z. — SEC Form 4 filings
SEC reporting owner CIK 1573553. 11 Form 4 filings on record with FilingPulse; latest filed 2026-07-13.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-01-19 to 2026-07-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 29.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| MARINUS PHARMACEUTICALS, INC. (MRNS) | Director | 3 | — | — | 16 |
| Esperion Therapeutics, Inc. (ESPR) | Director | 4 | — | — | 9 |
| Milestone Pharmaceuticals Inc. (MIST) | Director | 3 | — | — | 3 |
| AGILE THERAPEUTICS INC (AGRX) | Director | 1 | — | — | 1 |
Form 4 filings — Fischer Seth H. Z.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-13 | 4 | Esperion Therapeutics, Inc. (ESPR) | Disposition to issuer (D): 141,023 · Disposition to issuer (D): 21,000 (derivative) · Disposition to issuer (D): 32,500 (derivative) · Disposition to issuer (D): 44,000 (derivative) | EDGAR |
| 2026-06-12 | 4 | Milestone Pharmaceuticals Inc. (MIST) | Grant/award (A): 77,000 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | Esperion Therapeutics, Inc. (ESPR) | Grant/award (A): 79,873 @ $0 | EDGAR |
| 2025-06-12 | 4 | Milestone Pharmaceuticals Inc. (MIST) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | Esperion Therapeutics, Inc. (ESPR) | Grant/award (A): 33,000 @ $0 · Grant/award (A): 44,000 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | MARINUS PHARMACEUTICALS, INC. (MRNS) | Disposition to issuer (D): 12,707 @ $0.55 · Disposition to issuer (D): 2,300 @ $0.55 · Disposition to issuer (D): 10,450 (derivative) @ $0 · Disposition to issuer (D): 20,900 (derivative) @ $0 · Disposition to issuer (D): 16,200 (derivative) @ $0 · Disposition to issuer (D): 12,375 (derivative) @ $0 · +6 more | EDGAR |
| 2024-08-29 | 4 | Milestone Pharmaceuticals Inc. (MIST) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-08-26 | 4 | AGILE THERAPEUTICS INC (AGRX) | Disposition to issuer (D): 976 @ $1.52 | EDGAR |
| 2024-06-20 | 4 | MARINUS PHARMACEUTICALS, INC. (MRNS) | Grant/award (A): 2,300 @ $0 · Grant/award (A): 10,450 (derivative) @ $0 | EDGAR |
| 2024-05-24 | 4 | Esperion Therapeutics, Inc. (ESPR) | Grant/award (A): 23,000 @ $0 · Grant/award (A): 32,500 (derivative) @ $0 | EDGAR |
| 2024-01-19 | 4 | MARINUS PHARMACEUTICALS, INC. (MRNS) | Grant/award (A): 4,600 @ $0 · Grant/award (A): 20,900 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1573553 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →